| Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020 | 1549 | 2020 |
| A placebo-controlled trial of obeticholic acid in primary biliary cholangitis F Nevens, P Andreone, G Mazzella, SI Strasser, C Bowlus, P Invernizzi, ... New England Journal of Medicine 375 (7), 631-643, 2016 | 933 | 2016 |
| Cholangiocarcinoma 2020: the next horizon in mechanisms and management JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ... Nature Reviews Gastroenterology & Hepatology 17 (9), 557-588, 2020 | 921 | 2020 |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ... Nature reviews. Gastroenterology & hepatology 13 (5), 261-280, 2016 | 879 | 2016 |
| EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis GM Hirschfield, U Beuers, C Corpechot, P Invernizzi, D Jones, M Marzioni, ... Journal of hepatology 67 (1), 145-172, 2017 | 744 | 2017 |
| Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment C Selmi, MJ Mayo, N Bach, H Ishibashi, P Invernizzi, RG Gish, SC Gordon, ... Gastroenterology 127 (2), 485-492, 2004 | 541 | 2004 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 478 | 2021 |
| Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study WJ Lammers, HR Van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ... Gastroenterology 147 (6), 1338-1349. e5, 2014 | 447 | 2014 |
| Macrophage plasticity and polarization in liver homeostasis and pathology A Sica, P Invernizzi, A Mantovani Hepatology 59 (5), 2034-2042, 2014 | 440 | 2014 |
| Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ... Nature genetics 42 (8), 658-660, 2010 | 440 | 2010 |
| Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’ U Beuers, ME Gershwin, RG Gish, P Invernizzi, DEJ Jones, K Lindor, ... Gut 64 (11), 1671-1672, 2015 | 396 | 2015 |
| Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis JZ Liu, JR Hov, T Folseraas, E Ellinghaus, SM Rushbrook, NT Doncheva, ... Nature genetics 45 (6), 670-675, 2013 | 391 | 2013 |
| Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ... Gastroenterology 149 (7), 1804-1812. e4, 2015 | 386 | 2015 |
| Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis TJ Weismüller, PJ Trivedi, A Bergquist, M Imam, H Lenzen, CY Ponsioen, ... Gastroenterology 152 (8), 1975-1984. e8, 2017 | 368 | 2017 |
| Comparison of the clinical features and clinical course of antimitochondrial antibody‐positive and‐negative primary biliary cirrhosis P Invernizzi, A Crosignani, PM Battezzati, G Covini, G De Valle, A Larghi, ... Hepatology 25 (5), 1090-1095, 1997 | 332 | 1997 |
| High rates of 30-day mortality in patients with cirrhosis and COVID-19 M Iavarone, R D'Ambrosio, A Soria, M Triolo, N Pugliese, P Del Poggio, ... Journal of hepatology 73 (5), 1063-1071, 2020 | 319 | 2020 |
| Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic‐metabolizing bacterium C Selmi, DL Balkwill, P Invernizzi, AA Ansari, RL Coppel, M Podda, ... Hepatology 38 (5), 1250-1257, 2003 | 318 | 2003 |
| The X chromosome and immune associated genes I Bianchi, A Lleo, ME Gershwin, P Invernizzi Journal of autoimmunity 38 (2-3), J187-J192, 2012 | 317 | 2012 |
| Definition of human autoimmunity—autoantibodies versus autoimmune disease A Lleo, P Invernizzi, B Gao, M Podda, ME Gershwin Autoimmunity reviews 9 (5), A259-A266, 2010 | 304 | 2010 |
| Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development J Mouries, P Brescia, A Silvestri, I Spadoni, M Sorribas, R Wiest, E Mileti, ... Journal of hepatology 71 (6), 1216-1228, 2019 | 299 | 2019 |
